Article

wsj.com on 2016-04-05 23:23

FDA Approves Rheumatoid Arthritis Biosimilar

Related news

FDA approves Regeneron drug Kevzara for rheumatoid arthritis westfaironline.com
Canada , France , West Chester
FDA Approves First Biosimilar Drug wsj.com
Europe , China , Wall Street
PAmgen tackles rheumatoid arthritis with third biosimilar to get FDA OK pacbiztimes.com
Thousand Oaks
Health Canada Approves Celltrion’s Infliximab Biosimilar for Treatment of Rheumatoid Arthritis jdsupra.com
Canada
FDA Approves Amgen’s RIABNI™ (Rituximab-arrx) for Adults With Moderate to Severe Rheumatoid Arthritis jdsupra.com
FDA Approves 25th Biosimilar jdsupra.com
California , United States , Switzerland
Ushering in a New Era: FDA Approves First Interchangeable Biosimilar jdsupra.com
Europe , New Era
FDA Approves First Avastin Biosimilar jdsupra.com
FDA Approves Third Biosimilar Product jdsupra.com
FDA Approves First Rituximab Biosimilar jdsupra.com
California , United States , Switzerland
FDA Approves Pfizer’s EPO Biosimilar jdsupra.com
FDA Approves Another Interchangeable Biosimilar jdsupra.com
FDA Approves Sandoz’s Biosimilar Pegfilgrastim jdsupra.com
California , United States , Switzerland
FDA Approves Celltrion’s Trastuzumab Biosimilar jdsupra.com
California , United States , Switzerland
FDA Approves Sandoz Filgrastim Biosimilar jdsupra.com
FDA Approves Lantus® Interchangeable Biosimilar jdsupra.com
FDA rejects J&J application for new rheumatoid arthritis treatment bizjournals.com
Big-deal Gilead rheumatoid arthritis drug rejected by FDA bizjournals.com
Lilly’s rheumatoid arthritis pill rejected by regulators seattletimes.com
Europe
ALilly's rheumatoid arthritis pill rejected by regulators apnewsarchive.com
Europe